{"url_path":"/sec/sem/8-k/2026-07-01/item-5-01","section_key":"item-5-01","section_title":"Item 5.01 ****Changes in Control of Registrant.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1320414/0001104659-26-079643-index.html","accession_number":"0001104659-26-079643","cik":"0001320414","ticker":"SEM","issuer_name":"SELECT MEDICAL HOLDINGS CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1320414/0001104659-26-079643-index.html","primary_entity_key":"0001320414","primary_entity_name":"SELECT MEDICAL HOLDINGS CORP"},"word_count":153,"has_tables":true,"body_markdown":"**Item 5.01****Changes in Control of Registrant.**\n\n \n\nThe information set forth\nin the Introductory Note and under Items 2.01, 3.01, 3.03 and 5.03 of this Current Report is incorporated by reference into this Item\n5.01.\n\n \n\nAs a result of the consummation\nof the Merger, a change of control of the Company occurred, and the Company became a wholly-owned subsidiary of Parent and certain Rollover\nHolders (as defined in the Merger Agreement) that retained Company Restricted Shares in the surviving company. In connection with the\nMerger, the aggregate purchase price paid for all outstanding Company Shares (except as described in Item 2.01 of this Current Report)\nwas approximately $1.7 billion. The funds used to complete the Merger and the transactions contemplated thereby were provided by equity\ncontributions from funds managed by affiliates of Welsh, Carson, Anderson & Stowe, the Rollover (as defined in the Merger Agreement)\nby certain Rollover Holders and third-party debt financing.\n\n \n\n2"}